Dopamine-Dependent Iron Toxicity in Cells Derived from Rat Hypothalamus
Open accessThe DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
We report a new and specific mechanism for iron-mediated neurotoxicity using RCHT cells, which were derived from rat hypothalamus. RCHT cells exhibit immunofluorescent-positive markers for dopamine beta-hydroxylase and the norepinephrine transporter, NET. In the present study, we observed that iron-induced neurotoxicity in RCHT cells was dependent on (i) formation of an Fe-dopamine complex (100 microM FeCl3:100 microM dopamine); (ii) specific uptake of the Fe-dopamine complex into RCHT cells via NET (79+/-2 pmol 59Fe/mg/min; P<0.05), since the uptake of the 59Fe-dopamine complex by the cells was inhibited by 30 microM reboxetine, a specific NET inhibitor (78% inhibition, P<0.001); and (iii) intracellular oxidation of dopamine present in the Fe-dopamine complex to aminochrome; (iv) inhibition of DT-diaphorase, since incubation of RCHT cells with 100 microM Fe-dopamine complex in the presence of 100 microM dicoumarol, an inhibitor of DT-diaphorase, induced significant cell death (51+/-5%; P<0.001). However, this cell death was reduced by 75% when the cells were incubated in the presence of 30 microM reboxetine (P<0.01). No significant cell death was observed when the cells were incubated with 100 microM dopamine, 100 microM Fe-Dopamine complex, 100 microM dicoumarol, or 100 microM FeCl3 (8.3+/-2, 9+/-4, 8.5+/-3, or 9.7+/-2% of control, respectively). ESR studies using the spin trapping agent DMPO showed no formation of hydroxyl radicals when the cells were incubated with 100 microM FeCl3 alone. However, using the same ESR technique, the formation of hydroxyl radicals and a carbon-centered radical was detected when the cells were incubated with 100 microM Fe-dopamine complex in the presence of 100 microM dicoumarol. These studies suggest that iron can induce cell toxicity by a mechanism that requires the formation and NET-mediated uptake of an Fe-dopamine complex, ultimately resulting in the intracellular formation of reactive species.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“although dopamine is capable of reacting with iron directly to form a toxic complex (Arreguin et al. 2009; Paris et al. 2005) that probably itself catalyses hydroxyl formation.”
In the citing paper
“Cathecolamines, such as dopamine, might be oxidised to highly reactive or toxic quinones via the reduction of ferric iron or enzymatically.65–67”
From The role of iron in brain ageing and neurodegenerative disorders (2014) · cites this paper as [67]
Citations
Cites
Dexter, D. T., Wells, F. R., Lee, A. J., Agid, F., Agid, Y., Jenner, P., & Marsden, C. D. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb07264.x · Cited by 1,149
Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brain
Sofic, E., Riederer, P., Heinsen, H., Beckmann, H., Reynolds, G. P., Hebenstreit, G., & Youdim, M. B. H. (1988) · Journal of Neural Transmission · doi:10.1007/bf01244786 · Cited by 752
Sulzer, D., Bogulavsky, J., Larsen, K. E., Behr, G., Karatekin, E., Kleinman, M. H., Turro, N., Krantz, D., Edwards, R. H., Greene, L. A., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.22.11869 · Cited by 407
Berg, D., Roggendorf, W., Schröder, U., Klein, R., Tatschner, T., Benz, P., Tucha, O., Preier, M., Lange, K. W., Reiners, K., et al. (2002) · Archives of Neurology · doi:10.1001/archneur.59.6.999 · Cited by 377
Increased iron‐related MRI contrast in the substantia nigra in Parkinson's disease
Gorell, J. M., Ordidge, R. J., Brown, G. G., Deniau, J.-C., Buderer, N. M., & Helpern, J. A. (1995) · Neurology · doi:10.1212/wnl.45.6.1138 · Cited by 324
Morita, H., Ikeda, S., Yamamoto, K., Morita, S., Yoshida, K., Nomoto, S., Kato, M., & Yanagisawa, N. (1995) · Annals of Neurology · doi:10.1002/ana.410370515 · Cited by 246
Linert, W., Herlinger, E., Jameson, R. F., Kienzl, E., Jellinger, K., & Youdim, M. B. H. (1996) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/0925-4439(96)00020-8 · Cited by 238
Segura-Aguilar, J., & Lind, C. (1989) · Chemico-Biological Interactions · doi:10.1016/0009-2797(89)90006-9 · Cited by 192
Self-citationProta, G. (2000) · Pigment Cell Research · doi:10.1034/j.1600-0749.2000.130412.x · Cited by 134
Segura‐Aguilar, J., Metodiewa, D., & Welch, C. J. (1998) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/s0304-4165(98)00036-1 · Cited by 131
Self-citation
Research works printed but not linked: 6
- Dexter D. T., 1989, J. Neurochem., 52
- Linert W., 1996, Biochim. Biophys. Acta, 1316
- Segura-Aguilar J., 1998, Biochim. Biophys. Acta, 1381, 6
- Graumann R., 2002, Pol. J. Pharmacol., 54
- Smythies J., 2002, Neurotox. Res., 4, 81
- Sulzer D., 2000, Proc. Natl. Acad. Sci. U.S.A. 97
Cited by
The role of iron in brain ageing and neurodegenerative disorders
Ward, R. J., Zucca, F. A., Duyn, J. H., Crichton, R. R., & Zecca, L. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70117-6 · Cited by 1,819
Oxidative Stress and Neurotoxicity
Sayre, L. M., Perry, G., & Smith, M. A. (2008) · Chemical Research in Toxicology · doi:10.1021/tx700210j · Cited by 867
Interactions of iron, dopamine and neuromelanin pathways in brain aging and Parkinson's disease
Zucca, F. A., Segura-Aguilar, J., Ferrari, E., Muñoz, P., Paris, I., Sulzer, D., Sarna, T., Casella, L., & Zecca, L. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.09.012 · Cited by 659
Self-citationProtective and toxic roles of dopamine in Parkinson's disease
Segura‐Aguilar, J., Paris, I., Muñoz, P., Ferrari, E., Zecca, L., & Zucca, F. A. (2014) · Journal of Neurochemistry · doi:10.1111/jnc.12686 · Cited by 498
Self-citation8-Hydroxyquinolines: a review of their metal chelating properties and medicinal applications
Prachayasittikul, V., Prachayasittikul, V., Prachayasittikul, S., & Ruchirawat, S. (2013) · Drug Design, Development and Therapy · doi:10.2147/dddt.s49763 · Cited by 445
“35,36 Ladostigil contains the propargylamine moiety that accounts for its inhibition of the monoamine oxidase enzyme.”
Kell, D. B. (2010) · Archives of Toxicology · doi:10.1007/s00204-010-0577-x · Cited by 361
“Why these dopaminergic neurons are especially susceptible is not entirely clear, although dopamine is capable of reacting with iron directly to form a toxic complex (Arreguin et al. 2009; Paris et al. 2005) that probably itself catalyses hydroxyl formation.”
BackgroundIyanagi, T. (2007) · International Review of Cytology · doi:10.1016/s0074-7696(06)60002-8 · Cited by 290
Dopamine Oxidation and Autophagy
Muñoz, P., Huenchuguala, S., Paris, I., & Segura-Aguilar, J. (2012) · Parkinson's Disease · doi:10.1155/2012/920953 · Cited by 214
Self-citationDutta Chowdhury, A., & Doong, R.-A. (2016) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.6b06266 · Cited by 204
Benedetto, A., Au, C., Avila, D. S., Milatovic, D., & Aschner, M. (2010) · PLoS Genetics · doi:10.1371/journal.pgen.1001084 · Cited by 195
“Nature of the DA-derived oxidized species and oxidativestress pathways involved in PD The current literature provides a conceptual framework for addressing the synergistic mechanism of Mn and DA in DAergic neurodegeneration [76,137,138,139,140,141].”
BackgroundIron Storage within Dopamine Neurovesicles Revealed by Chemical Nano-Imaging
Ortega, R., Cloetens, P., Devès, G., Carmona, A., & Bohic, S. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000925 · Cited by 179
“Because dopamine can form stable complexes with iron in vitro [10,11], it has been”
BackgroundTrace metal imaging with high spatial resolution: Applications in biomedicine
Qin, Z., Caruso, J. A., Lai, B., Matusch, A., & Becker, J. S. (2011) · Metallomics · doi:10.1039/c0mt00048e · Cited by 169
Iron overload: Effects on cellular biochemistry
Sousa, L., Oliveira, M. M., Pessôa, M. T. C., & Barbosa, L. A. (2020) · Clinica Chimica Acta · doi:10.1016/j.cca.2019.11.029 · Cited by 138
Impact of Dopamine Oxidation on Dopaminergic Neurodegeneration
Zhang, S., Wang, R., & Wang, G. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00454 · Cited by 142
Hare, D. J., Lei, P., Ayton, S., Roberts, B. R., Grimm, R., George, J. L., Bishop, D., Beavis, A. D., Donovan, S. J., McColl, G., et al. (2014) · Chemical Science · doi:10.1039/c3sc53461h · Cited by 125
Feng, S.-T., Wang, Z.-Z., Yuan, Y.-H., Sun, H.-M., Chen, N.-H., & Zhang, Y. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.104336 · Cited by 96
Paris, I. B., Perez-Pastene, C., Cárdenas, S., Iturra, P., Muñoz, P., Couve, E., Caviedes, P. A., & Segura‐Aguilar, J. (2010) · Neurotoxicity Research · doi:10.1007/s12640-009-9148-4 · Cited by 93
Self-citationAutophagy Protects Against Aminochrome-Induced Cell Death in Substantia Nigra-Derived Cell Line
Paris, I., Muñoz, P., Huenchuguala, S., Couve, E., Sanders, L. H., Greenamyre, J. T., Caviedes, P., & Segura-Aguilar, J. (2011) · Toxicological Sciences · doi:10.1093/toxsci/kfr060 · Cited by 74
Self-citationParis, I., Perez-Pastene, C., Couve, E., Caviedes, P., LeDoux, S., & Segura-Aguilar, J. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m900323200 · Cited by 71
Self-citationHuenchuguala, S., Muñoz, P., Zavala, P., Villa, M., Cuevas, C., Ahumada, U., Graumann, R., Nore, B. F., Couve, E., Mannervik, B., et al. (2014) · Autophagy · doi:10.4161/auto.27720 · Cited by 65
Self-citationBaksi, S., Tripathi, A. K., & Singh, N. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.06.025 · Cited by 65
“Excess iron, on the other hand, aggregates α-syn [47] and converts dopamine to a toxic oxidation product [48, 49],”
Yao, S., Zhong, Y., Xu, Y., Qin, J., Zhang, N., Zhu, X., & Li, Y. (2017) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2017.00442 · Cited by 71
“On the other hand, excess iron can be harmful, generating toxic reactive oxygen species and facilitating a neurotoxic process, leading to highly reactive dopaminergic neurons, toxic quinones and even death via the Fenton reaction (Paris et al., 2005).”
BackgroundGal, S., Fridkin, M., Amit, T., Zheng, H., & Youdim, M. B. H. (2006) · Parkinson’s Disease and Related Disorders · doi:10.1007/978-3-211-45295-0_68 · Cited by 58
“On several occasions dopamine metabolism via autoxidation and by the reaction of MAO has been implicated to induce degeneration of nigrostriatal dopamine neurons (Riederer et al., 1989; Paris et al., 2005) (Fig.”
BackgroundHuang, Y., Chen, P., Zhou, L., Zheng, J., Wu, H., Liang, J., Xiao, A., Li, J., & Guan, B. (2023) · Advanced Materials · doi:10.1002/adma.202304116 · Cited by 61
Does retina play a role in Parkinson's Disease?
Devi, S. M., Iyer, M., Aswathy, N. P., Dhivya, V., & Vellingiri, B. (2020) · Acta Neurologica Belgica · doi:10.1007/s13760-020-01274-w · Cited by 56
Genetics and iron in the systems biology of Parkinson’s disease and some related disorders
Funke, C., Schneider, S. A., Berg, D., & Kell, D. B. (2013) · Neurochemistry International · doi:10.1016/j.neuint.2012.11.015 · Cited by 54
“Iron can also react with dopamine directly in the dopaminergic neurons of the SN to form a toxic complex (Arreguin et al., 2009; Paris et al., 2005) that itself probably catalyses hydroxyl formation.”
van Rensburg, Z. J., Abrahams, S., Bardien, S., & Kenyon, C. P. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02516-5 · Cited by 56
“Iron accumulation can lead to increased ROS and oxidized proteins which lead to oxidative damage in neurons [40, 69, 77, 138].”
BackgroundDynamics of Nigral Iron Accumulation in Parkinson's Disease: From Diagnosis to Late Stage
Du, G., Wang, E., Sica, C. T., Chen, H., Jesus, S. D., Lewis, M. M., Kong, L., Connor, J. R., Mailman, R. B., & Huang, X. (2022) · Movement Disorders · doi:10.1002/mds.29062 · Cited by 55
Reactivity of catecholamine-driven Fenton reaction and its relationships with iron(III) speciation
Melín, V., Henríquez, A., Freer, J., & Contreras, D. (2014) · Redox Report · doi:10.1179/1351000214y.0000000119 · Cited by 44
Jiang, D., Shi, S., Zhang, L., Liu, L., Ding, B., Zhao, B., Yagnik, G. B., & Zhou, F. (2013) · ACS Chemical Neuroscience · doi:10.1021/cn400105d · Cited by 41
Gogoi, S., Antonio, T., Rajagopalan, S., Reith, M. E. A., Andersen, J. K., & Dutta, A. K. (2011) · ChemMedChem · doi:10.1002/cmdc.201100140 · Cited by 40
Fate of L-DOPA in the Presence of Inorganic Matrices: Vectorization or Composite Material Formation?
Jaber, M., Bouchoucha, M., Delmotte, L., Méthivier, C., & Lambert, J. (2011) · The Journal of Physical Chemistry C · doi:10.1021/jp205050k · Cited by 43
Zhou, Z., Lan, Y. H., Tan, E. K., & Lim, T. M. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.09.010 · Cited by 46
Intense exercise potentiates oxidative stress in striatum of reserpine-treated animals
Teixeira, A. M., Reckziegel, P., Müller, L. G., Pereira, R. P., Roos, D. H., da Rocha, J. B. T., & Bürger, M. E. (2008) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2008.11.015 · Cited by 32
Paris, I. B., Cárdenas, S., Lozano, J., Perez-Pastene, C., Graumann, R., Chávez‐Riveros, A., Caviedes, P. A., & Segura‐Aguilar, J. (2007) · Neurotoxicity Research · doi:10.1007/bf03033921 · Cited by 31
Self-citationMolecular and Neurochemical Mechanisms in PD Pathogenesis
Paris, I. B., Lozano, J., Perez-Pastene, C., Muñoz, P., & Segura‐Aguilar, J. (2009) · Neurotoxicity Research · doi:10.1007/s12640-009-9059-4 · Cited by 32
“…cytochrome P450 forms, xanthine oxidase, tyrosinase, and dopamine b-monooxygenase) or transition metals (Smythies et al. 2002; Paris et al. 2001; Paris et al. 2005a, b; Galzigna et al. 2000; Thompson et al. 2000; Terland et al. 1997; Segura-Aguilar 1996; Foppoli et al. 1997; Hastings 1995;…”
InfluentialSelf-citationMechanisms of Dopamine Oxidation and Parkinson’s Disease
Segura‐Aguilar, J., & Paris, I. B. (2014) · Springer eBooks · doi:10.1007/978-1-4614-5836-4_16 · Cited by 30
Self-citationAdraa, K. E., Timón, V., Lambert, J., Al-Rabaa, A. R., Jaber, F., Jaber, M., & Tielens, F. (2012) · The Journal of Physical Chemistry C · doi:10.1021/jp3094148 · Cited by 31
Reduction reactivity of catecholamines and their ability to promote a Fenton reaction
Melín, V., Henríquez, A., Radojkovic, C., Schwederski, B. E., Kaim, W., Freer, J., & Contreras, D. (2016) · Inorganica Chimica Acta · doi:10.1016/j.ica.2016.07.044 · Cited by 26
Copper Neurotoxicity in Rat Substantia Nigra and Striatum Is Dependent on DT-Diaphorase Inhibition
Díaz‐Véliz, G., Paris, I. B., Mora, S., Raisman‐Vozari, R., & Segura‐Aguilar, J. (2008) · Chemical Research in Toxicology · doi:10.1021/tx8001143 · Cited by 24
Self-citationThe catecholaminergic RCSN-3 cell line: A model to study dopamine metabolism
Paris, I. B., Lozano, J., Cárdenas, S., Perez-Pastene, C., Saud, K., Fuentes, P., Caviedes, P. A., Dagnino‐Subiabre, A., Raisman‐Vozari, R., Shimahara, T., et al. (2008) · Neurotoxicity Research · doi:10.1007/bf03033505 · Cited by 21
Self-citationGonçalves, L. M. L., Ramkissoon, A., & Wells, P. G. (2009) · Chemical Research in Toxicology · doi:10.1021/tx800423s · Cited by 21
The role of metal ions in dopaminergic neuron degeneration in Parkinsonism and Parkinson’s disease
Paris, I. B., & Segura‐Aguilar, J. (2011) · Monatshefte für Chemie - Chemical Monthly · doi:10.1007/s00706-011-0478-6 · Cited by 20
Self-citationL-Theanine Decreases Orofacial Dyskinesia Induced by Reserpine in Rats
Soung, H.-S., Wang, M., Chang, K.-C., Chen, C.-N., Chang, Y., Yang, C.-C., & Tseng, H.-C. (2018) · Neurotoxicity Research · doi:10.1007/s12640-018-9897-z · Cited by 22
“RES also causes disruption in neurotransmission by affecting the vesicular monoamine transporter (VMAT) to restrict the storage of DA in synaptic vesicles, resulting in an accelerated rate of cytosolic DA oxidative metabolism bymonoamine oxidase (MAO) (Fuentes et al. 2007; Kronbauer et al. 2015; de Freitas et al. 2016…”
BackgroundInfluentialXu, Y., Zhang, B., Wu, S., & Xia, Y. (2009) · Analytica Chimica Acta · doi:10.1016/j.aca.2009.06.058 · Cited by 18
Gómez, F. J., Aguirre, P., González-Billault, C. E., & Núñez, M. T. (2010) · Journal of Neural Transmission · doi:10.1007/s00702-010-0489-1 · Cited by 18
“Another source of free radicals derives from the nonenzymatic oxidation of dopamine induced by iron, which produces semiquinones and H2O2 (Paris et al. 2005; Zoccarato et al. 2005).”
Nishino, Y., Ando, M., Makino, R., Ueda, K., Okamoto, Y., & Kojima, N. (2010) · Neurotoxicity Research · doi:10.1007/s12640-010-9226-7 · Cited by 17
Wang, M., Lin, R.-F., Tseng, H.-C., Soung, H.-S., Chang, K.-C., & Tsai, C.-C. (2015) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2015.02.003 · Cited by 13
Clioquinol Protects Against Cell Death in Parkinson’s Disease Models In Vivo and In Vitro
Wilkins, S., Masters, C. L., Bush, A. I., Cherny, R. A., & Finkelstein, D. I. (2009) · Advances in behavioral biology · doi:10.1007/978-1-4419-0340-2_33 · Cited by 14
“Adding Fe or Fe did not result in increased cell death due to iron interacting with DA and forming the non-toxic aminochrome and little or no hydrogen peroxide (Izumi et al. 2005; Paris et al. 2005).”
BackgroundTan, H., Hubertus, S., Thomas, S., Lee, A. M., Gerhardt, S., Gerchen, M. F., Sommer, W. H., Kiefer, F., Schad, L. R., & Vollstädt‐Klein, S. (2022) · Psychopharmacology · doi:10.1007/s00213-022-06301-7 · Cited by 12
“2012), and iron was found as a mediator of the neurotoxicity in Parkinson’s disease via Fe − dopamine complex (Paris et al. 2005).”
BackgroundHényková, E., Kaleta, M., Klíčová, K., Gonzalez, G. A., Novák, O., Strnad, M., & Kaňovský, P. (2022) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.2c00516 · Cited by 6
Catecholaminergic Cell Lines for the Study of Dopamine Metabolism and Neurotoxicity
Segura‐Aguilar, J. (2011) · Neuromethods · doi:10.1007/978-1-61779-077-5_19 · Cited by 6
Self-citationKumamoto, K., Hirai, T., Kishioka, S., & Iwahashi, H. (2007) · Free Radical Research · doi:10.1080/10715760701236758 · Cited by 5
“Hydroxyl radicals and carbon-centered radicals were detected when cells, derived from rat hypothalamus, were incubated with 100mM Fe–dopamine complex in the presence of 100mM dicoumarol [10].”
MethodThe role of metal ions in dopaminergic neuron degeneration in Parkinsonism and Parkinson’s disease
Paris, I. B., & Segura‐Aguilar, J. (2012) · Springer eBooks · doi:10.1007/978-3-7091-1001-0_3 · Cited by 4
Self-citationMechanisms of Dopamine Oxidation and Parkinson’s Disease
Segura‐Aguilar, J., & Paris, I. B. (2022) · Springer eBooks · doi:10.1007/978-3-031-15080-7_16 · Cited by 3
Self-citationMuñoz, P., Meléndez, C., Paris, I. B., & Segura‐Aguilar, J. (2015) · Current topics in neurotoxicity · doi:10.1007/978-3-319-13939-5_11 · Cited by 6
Self-citationLitvinenko, I., & Вячеславович, К. И. (2021) · Russian Military Medical Academy Reports · doi:10.17816/rmmar83609 · Cited by 2
Mechanisms of Dopamine Oxidation and Parkinson’s Disease
Segura‐Aguilar, J., & Paris, I. B. (2022) · Springer eBooks · doi:10.1007/978-3-030-71519-9_16-1 · Cited by 5
Self-citationFerroptosis in the Pathogenesis of Alzheimer’s Disease: The New Evidence for Validation of FAB Model
Aghajanov, M. I., Harutyunyan, H. S., Khamperyan, A., Karapetyan, G. A., Fereshetyan, K., & Yenkoyan, K. B. (2023) · Neurochemical Journal · doi:10.1134/s1819712423040049 · Cited by 3
Dopamine and L-Dopa as Selective Endogenous Neurotoxins
Segura‐Aguilar, J., Ahumada-Castro, U., & Paris, I. B. (2022) · Springer eBooks · doi:10.1007/978-3-031-15080-7_70 · Cited by 3
Self-citationLee, S. H., Matsumoto, N., Terada, A., Hatakawa, Y., & Oe, T. (2025) · Scientific Reports · doi:10.1038/s41598-025-31292-8 · Cited by 2
“Transition metals, such as Cu and Fe, also induce or accelerate the oxidation of DA 14,15 .”
Early-life iron exposure disrupts dopaminergic neuron function and neurobehaviour in zebrafish
Nguyen, T. M. N., Naderi, M., Chandrapalan, T., & Kwong, R. W. M. (2026) · NeuroToxicology · doi:10.1016/j.neuro.2026.103437 · Cited by 1
Dopamine and L-dopa as Selective Endogenous Neurotoxins
Segura‐Aguilar, J., Ahumada-Castro, U., & Paris, I. B. (2014) · Springer eBooks · doi:10.1007/978-1-4614-5836-4_70
Self-citationNovel mechanisms of quinone toxicity
Xiong, R. (2015) · doi:10.25677/pwc8-7f10
Teixeira, A. M. (2008) · Americanae (AECID Library)
Applications of Nuclear Analytical Techniques for Iron-omics Studies
Nie, G., Zhu, M., & Ning, B. (2010) · Royal Society of Chemistry eBooks · doi:10.1039/9781847559913-00239
Ion-Catalyzed Reactive Oxygen Species in Sporadic Models of Parkinson’s Disease
Vasquez, V., Mitra, J., Guerrero, E. N., Hegde, P. M., Rao, K. S. J., & Hegde, M. L. (2016) · Springer eBooks · doi:10.1007/978-3-319-42139-1_5
Ramkissoon, A. (2012) · TSpace (University of Toronto)
Peethambaran, B., Leonce, C., & Patel, A. (2021) · International Journal of Complementary & Alternative Medicine · doi:10.15406/ijcam.2021.14.00528
Evaluation of Analytes Characterized with Potential Protective Action after Rat Exposure to Lead
Liakh, I., Harshkova, D., Pauliukavets, A. Y., Шейбак, В. М., Bączek, T., & Miękus, N. (2021) · Molecules · doi:10.3390/molecules26082163
“On the other hand, a decrease in DA levels may be due to inhibition of enzymes of its synthesis [29], and also possibly due to the formation of a complex of DA with Pb, as it happens with iron intoxication [30].”
BackgroundDopamine and L-Dopa as Selective Endogenous Neurotoxins
Segura‐Aguilar, J., Ahumada-Castro, U., & Paris, I. B. (2021) · Springer eBooks · doi:10.1007/978-3-030-71519-9_70-1
Self-citationHoushmand, G., Nikbakht, J., Mahmoudi, M., Assadpour, S., Firozjae, A. A., Arimi, A., & Almasian, E. (2021) · Armaghane Danesh · doi:10.52547/armaghanj.26.5.744 · Cited by 1
Levodopa increases substantia nigra iron: implications for Parkinson’s diseasePreprint
Du, G., Bransom, L., Zhou, M., Sica, C. T., Huang, X., Yang, Y., & Mailman, R. B. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.05.26.728066
Chemically Reconfigurable Neuromorphic Electronics for Neurochemical HomeostasisPreprint
Wang, T., Peng, S., Xu, Q., Zou, H., Chen, Z., Song, G., zhang, F., Xia, L., Zhou, R., Hao, W., et al. (2026) · Research Square · doi:10.21203/rs.3.rs-11182543/v1
Metadata
- Authors
- Paris, I., Martinez-Alvarado, P., Cárdenas, S., Perez-Pastene, C., Graumann, R., Fuentes, P., Olea-Azar, C., Caviedes, P., & Segura-Aguilar, J.
- Affiliations
- University of Chile (CL)
- Program of Molecular and Clinical Pharmacology, ICBM, Faculty of Medicine, and Department of Biophysics, Faculty of Chemistry and Pharmacy, University of Chile, Casilla 70000, Santiago-7, Chile
- Venue
- Chemical Research in Toxicology
- Publisher
- American Chemical Society (ACS)
- Published
- 2005-01-28
- Volume
- 18
- Issue
- 3
- Pages
- 415-419
- ISSN
- 0893-228X (ISSN-L)
- 1520-5010
- OpenAlex
- W2081705343
- Cited by
- 74
- References
- 26
- Citations by year
- 2026: 3 · 2025: 1 · 2023: 2 · 2022: 6 · 2021: 6 · 2020: 1 · 2019: 2 · 2018: 2 · 2017: 1 · 2016: 4 · 2015: 4 · 2014: 7 · 2013: 2 · 2012: 5
- FWCI
- 1.97
- Type
- journal article
- Language
- en
- Open access
- green
- americanae.aecid.es
- Licence
- other-oa
- Locations
- Chemical Research in Toxicology (publishedVersion)
- PubMed (publishedVersion)
- Americanae (AECID Library) (submittedVersion, other-oa)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, other-oa)
- Universidad de Chile (submittedVersion)
- Topics
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Physical Sciences › Environmental Science › Health, Toxicology and Mutagenesis › Heavy Metal Exposure and Toxicity
- Life Sciences › Neuroscience › Neurology › Neurological diseases and metabolism
- Keywords
- iron toxicity, dopamine, neurotoxicity, norepinephrine transporter, hypothalamic neurons, DT-diaphorase, dicumarol, reboxetine, aminochrome, hydroxyl radicals, carbon-centered radicals, cell death, iron absorption, EPR spin trapping, DMPO, iron-59
- MeSH terms
- Reboxetine, Animals, Dicumarol, Cell Line, Chlorides, Dopamine, Dopamine beta-Hydroxylase, Ferric Compounds, Fluorescent Antibody Technique, Hypothalamus, Iron, Morpholines, Rats, Inbred F344, NAD(P)H Dehydrogenase (Quinone), Cell Death, Microscopy, Confocal, Adrenergic Uptake Inhibitors, Symporters, Indolequinones, Norepinephrine Plasma Membrane Transport Proteins, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.